{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:11:37Z","timestamp":1775002297535,"version":"3.50.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,10,19]],"date-time":"2017-10-19T00:00:00Z","timestamp":1508371200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,10,19]],"date-time":"2017-10-19T00:00:00Z","timestamp":1508371200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Leukotriene A4 Hydrolase (LTA4H) is a bifunctional zinc metalloenzyme that comprises both epoxide hydrolase and aminopeptidase activity, exerted by two overlapping catalytic sites. The epoxide hydrolase function of the enzyme catalyzes the biosynthesis of the pro-inflammatory lipid mediator leukotriene (LT) B4. Recent literature suggests that the aminopeptidase function of LTA4H is responsible for degradation of the tripeptide Pro-Gly-Pro (PGP) for which neutrophil chemotactic activity has been postulated. It has been speculated that the design of epoxide hydrolase selective LTA4H inhibitors that spare the aminopeptidase pocket may therefore lead to more efficacious anti-inflammatory drugs. In this study, we conducted a high throughput screen (HTS) for LTA4H inhibitors and attempted to rationally design compounds that would spare the PGP degrading function. While we were able to identify compounds with preference for the epoxide hydrolase function, absolute selectivity was not achievable for highly potent compounds. In order to assess the relevance of designing such aminopeptidase-sparing LTA4H inhibitors, we studied the role of PGP in inducing inflammation in different settings in wild type and LTA4H deficient (LTA4H KO) animals but could not confirm its chemotactic potential. \u00a0Attempting to design highly potent epoxide hydrolase selective LTA4H inhibitors, therefore seems to be neither feasible nor relevant.<\/jats:p>","DOI":"10.1038\/s41598-017-13490-1","type":"journal-article","created":{"date-parts":[[2017,10,13]],"date-time":"2017-10-13T14:32:19Z","timestamp":1507905139000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Feasibility and physiological relevance of designing highly potent aminopeptidase-sparing leukotriene A4 hydrolase inhibitors"],"prefix":"10.1038","volume":"7","author":[{"given":"Shin","family":"Numao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franziska","family":"Hasler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire","family":"Laguerre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Honnappa","family":"Srinivas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathalie","family":"Wack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petra","family":"J\u00e4ger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andres","family":"Schmid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnaud","family":"Osmont","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrik","family":"R\u00f6thlisberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeremy","family":"Houguenade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Bergsdorf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4615-4091","authenticated-orcid":false,"given":"Janet","family":"Dawson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathalie","family":"Carte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Hofmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Markert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liz","family":"Hardaker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Billich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Romain M.","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos A.","family":"Penno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Birgit","family":"Bollbuck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang","family":"Miltz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Till A.","family":"R\u00f6hn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,10,19]]},"reference":[{"key":"13490_CR1","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/nri3859","volume":"15","author":"EA Dennis","year":"2015","unstructured":"Dennis, E. A. & Norris, P. C. Eicosanoid storm in infection and inflammation. Nat Rev Immunol 15, 511\u2013523 (2015).","journal-title":"Nat Rev Immunol"},{"key":"13490_CR2","doi-asserted-by":"publisher","first-page":"50639","DOI":"10.1074\/jbc.R400027200","volume":"279","author":"JZ Haeggstrom","year":"2004","unstructured":"Haeggstrom, J. Z. Leukotriene A4 hydrolase\/aminopeptidase, the gatekeeper of chemotactic leukotriene B4 biosynthesis. J Biol Chem 279, 50639\u201350642 (2004).","journal-title":"J Biol Chem"},{"key":"13490_CR3","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1056\/NEJMra071371","volume":"357","author":"M Peters-Golden","year":"2007","unstructured":"Peters-Golden, M. & Henderson, W. R. Leukotrienes. N Engl J Med 357, 1841\u20131854 (2007).","journal-title":"N Engl J Med"},{"key":"13490_CR4","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/B978-0-12-394300-2.00002-8","volume":"116","author":"A Di Gennaro","year":"2012","unstructured":"Di Gennaro, A. & Haeggstrom, J. Z. The leukotrienes: immune-modulating lipid mediators of disease. Adv Immunol 116, 51\u201392 (2012).","journal-title":"Adv Immunol"},{"key":"13490_CR5","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1517\/14728222.2013.843671","volume":"18","author":"A Di Gennaro","year":"2014","unstructured":"Di Gennaro, A. & Haeggstrom, J. Z. Targeting leukotriene B4 in inflammation. Expert Opin Ther Targets 18, 79\u201393 (2014).","journal-title":"Expert Opin Ther Targets"},{"key":"13490_CR6","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/BF02737600","volume":"17","author":"JZ Haeggstrom","year":"1999","unstructured":"Haeggstrom, J. Z. Leukotriene A4 hydrolase and the committed step in leukotriene B4 biosynthesis. Clin Rev Allergy Immunol 17, 111\u2013131 (1999).","journal-title":"Clin Rev Allergy Immunol"},{"key":"13490_CR7","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1007\/s00726-014-1694-2","volume":"46","author":"A Byzia","year":"2014","unstructured":"Byzia, A., Haeggstrom, J. Z., Salvesen, G. S. & Drag, M. A remarkable activity of human leukotriene A4 hydrolase (LTA4H) toward unnatural amino acids. Amino Acids 46, 1313\u20131320 (2014).","journal-title":"Amino Acids"},{"key":"13490_CR8","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/nm1361","volume":"12","author":"NM Weathington","year":"2006","unstructured":"Weathington, N. M. et al. A novel peptide CXCR ligand derived from extracellular matrix degradation during airway inflammation. Nat Med 12, 317\u2013323 (2006).","journal-title":"Nat Med"},{"key":"13490_CR9","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1126\/science.1190594","volume":"330","author":"RJ Snelgrove","year":"2010","unstructured":"Snelgrove, R. J. et al. A critical role for LTA4H in limiting chronic pulmonary neutrophilic inflammation. Science 330, 90\u201394 (2010).","journal-title":"Science"},{"key":"13490_CR10","doi-asserted-by":"publisher","first-page":"5662","DOI":"10.4049\/jimmunol.180.8.5662","volume":"180","author":"A Gaggar","year":"2008","unstructured":"Gaggar, A. et al. A novel proteolytic cascade generates an extracellular matrix-derived chemoattractant in chronic neutrophilic inflammation. J Immunol 180, 5662\u20135669 (2008).","journal-title":"J Immunol"},{"key":"13490_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms9423","volume":"6","author":"S Akthar","year":"2015","unstructured":"Akthar, S. et al. Matrikines are key regulators in modulating the amplitude of lung inflammation in acute pulmonary infection. Nat Commun 6, 8423 (2015).","journal-title":"Nat Commun"},{"key":"13490_CR12","doi-asserted-by":"publisher","first-page":"6549","DOI":"10.1016\/j.bmcl.2008.10.044","volume":"18","author":"X Jiang","year":"2008","unstructured":"Jiang, X. et al. Activation and inhibition of leukotriene A4 hydrolase aminopeptidase activity by diphenyl ether and derivatives. Bioorg Med Chem Lett 18, 6549\u20136552 (2008).","journal-title":"Bioorg Med Chem Lett"},{"key":"13490_CR13","doi-asserted-by":"publisher","first-page":"6746","DOI":"10.1016\/j.bmcl.2011.09.048","volume":"21","author":"EO De Oliveira","year":"2011","unstructured":"De Oliveira, E. O. et al. Effect of the leukotriene A4 hydrolase aminopeptidase augmentor 4-methoxydiphenylmethane in a pre-clinical model of pulmonary emphysema. Bioorg Med Chem Lett 21, 6746\u20136750 (2011).","journal-title":"Bioorg Med Chem Lett"},{"key":"13490_CR14","doi-asserted-by":"publisher","first-page":"4227","DOI":"10.1073\/pnas.1402136111","volume":"111","author":"A Stsiapanava","year":"2014","unstructured":"Stsiapanava, A. et al. Binding of Pro-Gly-Pro at the active site of leukotriene A4 hydrolase\/aminopeptidase and development of an epoxide hydrolase selective inhibitor. Proc Natl Acad Sci USA 111, 4227\u20134232 (2014).","journal-title":"Proc Natl Acad Sci USA"},{"key":"13490_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/srep44449","volume":"7","author":"CM Low","year":"2017","unstructured":"Low, C. M. et al. The development of novel LTA4H modulators to selectively target LTB4 generation. Sci Rep 7, 44449 (2017).","journal-title":"Sci Rep"},{"key":"13490_CR16","first-page":"1173","volume":"10","author":"AM Fourie","year":"2009","unstructured":"Fourie, A. M. Modulation of inflammatory disease by inhibitors of leukotriene A4 hydrolase. Curr Opin Investig Drugs 10, 1173\u20131182 (2009).","journal-title":"Curr Opin Investig Drugs"},{"key":"13490_CR17","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.chembiol.2008.07.018","volume":"15","author":"F Tholander","year":"2008","unstructured":"Tholander, F. et al. Structure-based dissection of the active site chemistry of leukotriene A4 hydrolase: implications for M1 aminopeptidases and inhibitor design. Chem Biol 15, 920\u2013929 (2008).","journal-title":"Chem Biol"},{"key":"13490_CR18","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1124\/jpet.106.115436","volume":"321","author":"NL Rao","year":"2007","unstructured":"Rao, N. L. et al. Anti-inflammatory activity of a potent, selective leukotriene A4 hydrolase inhibitor in comparison with the 5-lipoxygenase inhibitor zileuton. J Pharmacol Exp Ther 321, 1154\u20131160 (2007).","journal-title":"J Pharmacol Exp Ther"},{"key":"13490_CR19","doi-asserted-by":"crossref","first-page":"6810","DOI":"10.4049\/jimmunol.163.12.6810","volume":"163","author":"RS Byrum","year":"1999","unstructured":"Byrum, R. S., Goulet, J. L., Snouwaert, J. N., Griffiths, R. J. & Koller, B. H. Determination of the contribution of cysteinyl leukotrienes and leukotriene B4 in acute inflammatory responses using 5-lipoxygenase- and leukotriene A4 hydrolase-deficient mice. J Immunol 163, 6810\u20136819 (1999).","journal-title":"J Immunol"},{"key":"13490_CR20","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1021\/jm900838g","volume":"53","author":"V Sandanayaka","year":"2010","unstructured":"Sandanayaka, V. et al. Discovery of 4-[(2S)-2-{[4-(4-chlorophenoxy)phenoxy]methyl}-1-pyrrolidinyl]butanoic acid (DG-051) as a novel leukotriene A4 hydrolase inhibitor of leukotriene B4 biosynthesis. J Med Chem 53, 573\u2013585 (2010).","journal-title":"J Med Chem"},{"key":"13490_CR21","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jneuroim.2009.09.020","volume":"217","author":"PJ O\u2019Reilly","year":"2009","unstructured":"O\u2019Reilly, P. J. et al. Neutrophils contain prolyl endopeptidase and generate the chemotactic peptide, PGP, from collagen. J Neuroimmunol 217, 51\u201354 (2009).","journal-title":"J Neuroimmunol"},{"key":"13490_CR22","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1084\/jem.20052371","volume":"203","author":"M Chen","year":"2006","unstructured":"Chen, M. et al. Neutrophil-derived leukotriene B4 is required for inflammatory arthritis. J Exp Med 203, 837\u2013842 (2006).","journal-title":"J Exp Med"},{"key":"13490_CR23","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1164\/rccm.200807-1158OC","volume":"181","author":"NL Rao","year":"2010","unstructured":"Rao, N. L. et al. Leukotriene A(4) hydrolase inhibition attenuates allergic airway inflammation and hyperresponsiveness. Am J Respir Crit Care Med 181, 899\u2013907 (2010).","journal-title":"Am J Respir Crit Care Med"},{"key":"13490_CR24","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1038\/sj.bjp.0707645","volume":"153","author":"BJ Whittle","year":"2008","unstructured":"Whittle, B. J. et al. Attenuation of inflammation and cytokine production in rat colitis by a novel selective inhibitor of leukotriene A4 hydrolase. Br J Pharmacol 153, 983\u2013991 (2008).","journal-title":"Br J Pharmacol"},{"key":"13490_CR25","doi-asserted-by":"publisher","first-page":"3403","DOI":"10.1096\/fj.07-096230","volume":"22","author":"AH Van Houwelingen","year":"2008","unstructured":"Van Houwelingen, A. H. et al. Induction of lung emphysema is prevented by L-arginine-threonine-arginine. FASEB J 22, 3403\u20133408 (2008).","journal-title":"FASEB J"},{"key":"13490_CR26","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1517\/17460441.2013.735228","volume":"8","author":"B Caliskan","year":"2013","unstructured":"Caliskan, B. & Banoglu, E. Overview of recent drug discovery approaches for new generation leukotriene A4 hydrolase inhibitors. Expert Opin Drug Discov 8, 49\u201363 (2013).","journal-title":"Expert Opin Drug Discov"},{"key":"13490_CR27","first-page":"2427","volume":"40","author":"JL Haddox","year":"1999","unstructured":"Haddox, J. L. et al. Bioactivity of peptide analogs of the neutrophil chemoattractant, N-acetyl-proline-glycine-proline. Invest Ophthalmol Vis Sci 40, 2427\u20132429 (1999).","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"13490_CR28","first-page":"1306","volume":"36","author":"RR Pfister","year":"1995","unstructured":"Pfister, R. R., Haddox, J. L., Sommers, C. I. & Lam, K. W. Identification and synthesis of chemotactic tripeptides from alkali-degraded whole cornea. A study of N-acetyl-proline-glycine-proline and N-methyl-proline-glycine-proline. Invest Ophthalmol Vis Sci 36, 1306\u20131316 (1995).","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"13490_CR29","doi-asserted-by":"publisher","first-page":"4423","DOI":"10.4049\/jimmunol.0802457","volume":"182","author":"MT Hardison","year":"2009","unstructured":"Hardison, M. T. et al. The presence of a matrix-derived neutrophil chemoattractant in bronchiolitis obliterans syndrome after lung transplantation. J Immunol 182, 4423\u20134431 (2009).","journal-title":"J Immunol"},{"key":"13490_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0015781","volume":"6","author":"X Xu","year":"2011","unstructured":"Xu, X. et al. A self-propagating matrix metalloprotease-9 (MMP-9) dependent cycle of chronic neutrophilic inflammation. PLoS One 6, e15781 (2011).","journal-title":"PLoS One"},{"key":"13490_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0031701","volume":"7","author":"A Secatto","year":"2012","unstructured":"Secatto, A. et al. 5-Lipoxygenase deficiency impairs innate and adaptive immune responses during fungal infection. PLoS One 7, e31701 (2012).","journal-title":"PLoS One"},{"key":"13490_CR32","doi-asserted-by":"crossref","first-page":"5221","DOI":"10.4049\/jimmunol.157.12.5221","volume":"157","author":"MB Bailie","year":"1996","unstructured":"Bailie, M. B. et al. Leukotriene-deficient mice manifest enhanced lethality from Klebsiella pneumonia in association with decreased alveolar macrophage phagocytic and bactericidal activities. J Immunol 157, 5221\u20135224 (1996).","journal-title":"J Immunol"},{"key":"13490_CR33","doi-asserted-by":"publisher","first-page":"5059","DOI":"10.4049\/jimmunol.1400452","volume":"192","author":"M Paige","year":"2014","unstructured":"Paige, M. et al. Role of leukotriene A4 hydrolase aminopeptidase in the pathogenesis of emphysema. J Immunol 192, 5059\u20135068 (2014).","journal-title":"J Immunol"},{"key":"13490_CR34","doi-asserted-by":"publisher","first-page":"L749","DOI":"10.1152\/ajplung.00116.2010","volume":"299","author":"YM Shim","year":"2010","unstructured":"Shim, Y. M. et al. Role of LTB(4) in the pathogenesis of elastase-induced murine pulmonary emphysema. Am J Physiol Lung Cell Mol Physiol 299, L749\u2013759 (2010).","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"13490_CR35","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.pupt.2014.06.003","volume":"29","author":"W Barchuk","year":"2014","unstructured":"Barchuk, W. et al. Effects of JNJ-40929837, a leukotriene A4 hydrolase inhibitor, in a bronchial allergen challenge model of asthma. Pulm Pharmacol Ther 29, 15\u201323 (2014).","journal-title":"Pulm Pharmacol Ther"},{"key":"13490_CR36","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1183\/13993003.00536-2015","volume":"46","author":"GM Gauvreau","year":"2015","unstructured":"Gauvreau, G. M., El-Gammal, A. I. & O\u2019Byrne, P. M. Allergen-induced airway responses. Eur Respir J 46, 819\u2013831 (2015).","journal-title":"Eur Respir J"},{"key":"13490_CR37","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/cts.12428","volume":"10","author":"JS Elborn","year":"2017","unstructured":"Elborn, J. S. et al. Phase I Studies of Acebilustat: Biomarker Response and Safety in Patients with Cystic Fibrosis. Clin Transl Sci 10, 28\u201334 (2017).","journal-title":"Clin Transl Sci"},{"key":"13490_CR38","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1107\/S0907444904015215","volume":"60","author":"M Kroemer","year":"2004","unstructured":"Kroemer, M., Dreyer, M. K. & Wendt, K. U. APRV - a program for automated data processing, refinement and visualization. Acta Crystallogr D Biol Crystallogr 60, 1679\u20131682 (2004).","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"13490_CR39","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1107\/S0021889807021206","volume":"40","author":"AJ McCoy","year":"2007","unstructured":"McCoy, A. J. et al. Phaser crystallographic software. J Appl Crystallogr 40, 658\u2013674 (2007).","journal-title":"J Appl Crystallogr"},{"key":"13490_CR40","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1107\/S0907444904019158","volume":"60","author":"P Emsley","year":"2004","unstructured":"Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr 60, 2126\u20132132 (2004).","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"13490_CR41","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1107\/S0907444903017694","volume":"59","author":"G Bricogne","year":"2003","unstructured":"Bricogne, G., Vonrhein, C., Flensburg, C., Schiltz, M. & Paciorek, W. Generation, representation and flow of phase information in structure determination: recent developments in and around SHARP 2.0. Acta Crystallogr D Biol Crystallogr 59, 2023\u20132030 (2003).","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"13490_CR42","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1177\/1087057107299873","volume":"12","author":"AM Liang","year":"2007","unstructured":"Liang, A. M. et al. Development of a homogeneous time-resolved fluorescence leukotriene B4 assay for determining the activity of leukotriene A4 hydrolase. J Biomol Screen 12, 536\u2013545 (2007).","journal-title":"J Biomol Screen"},{"key":"13490_CR43","doi-asserted-by":"publisher","first-page":"5637","DOI":"10.1016\/S0040-4039(99)01050-3","volume":"40","author":"BA Kulkarni","year":"1999","unstructured":"Kulkarni, B. A. Solution-phase parallel oxazone synthesis with TosMic. Tetrahedron Letters 40, 5637\u20135638 (1999).","journal-title":"Tetrahedron Letters"},{"key":"13490_CR44","doi-asserted-by":"publisher","first-page":"4150","DOI":"10.1021\/jm701575k","volume":"51","author":"CA Grice","year":"2008","unstructured":"Grice, C. A. et al. Identification of a potent, selective, and orally active leukotriene a4 hydrolase inhibitor with anti-inflammatory activity. J Med Chem 51, 4150\u20134169 (2008).","journal-title":"J Med Chem"},{"key":"13490_CR45","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1002\/ardp.200500101","volume":"338","author":"D Rakowitz","year":"2005","unstructured":"Rakowitz, D. et al. Synthesis of novel benzoic acid derivatives with benzothiazolyl subunit and evaluation as aldose reductase inhibitors. Arch Pharm (Weinheim) 338, 411\u2013418 (2005).","journal-title":"Arch Pharm (Weinheim)"},{"key":"13490_CR46","unstructured":"Bacani G. M. et al. Thiazolopyridin-2-yloxy-phenyl and thiazolopyrazin-2-yloxy-phenyl amines as modulators of leukotriene A4 hydrolase and their preparation and pharmaceutical compositions. United States patent US 2008-61044349. 2008 Apr 11."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-13490-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-13490-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-13490-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,27]],"date-time":"2023-08-27T04:09:10Z","timestamp":1693109350000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-13490-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,19]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["13490"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-13490-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,19]]},"assertion":[{"value":"10 May 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"We disclose that all authors are current or former employees of, and hold company stocks or stock options with Novartis Pharma AG.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"13591"}}